Qinglian Wen

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Combination Therapy

Replacement Therapy

Top Venues

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Zheng Li, Yi Zhang, Ying Li, Xi Chen, Jie Hu, Jiayun Yu, Yuzhu Hu, Shihong Nie, Nanjing Li, Qinglian Wen, Bingwen Zou
Letter to the Editor: Is the evidence convincing for the expansion of CHB treatment criteria to reduce the risk of HCC? Hepatology (Baltimore, Md.) 80 (3) (2024)
Zheng Li, Yi Zhang, Ying Li, Xi Chen, Jie Hu, Jiayun Yu, Yuzhu Hu, Shihong Nie, Nanjing Li, Qinglian Wen, Bingwen Zou
Letter to the Editor: Is the evidence convincing for the expansion of CHB treatment criteria to reduce the risk of HCC? Hepatology (Baltimore, Md.) (2024)
Zheng Li, Yi Zhang, Ying Li, Xi Chen, Jie Hu, Jiayun Yu, Yuzhu Hu, Shihong Nie, Nanjing Li, Qinglian Wen, Bingwen Zou
Letter to the Editor: Is the evidence convincing for the expansion of CHB treatment criteria to reduce the risk of HCC? Hepatology (Baltimore, Md.) 80 (3) (2024)